U.S. FDA advisers back Moderna vaccine for ages 6+

U.S. FDA advisers back Moderna vaccine for ages 6+

Advisers to the U.S. Food and Drug Administration on Tuesday unanimously recommended that the agency authorize Moderna Inc’s MRNA.O COVID-19 vaccine for children and teens aged 6 to 17 years of age. Jayson Albano reports.